HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Paromomycin Sulfate

HCID 441375
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1263-89-4
Standard SMILES
NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O.O=S(=O)(O)O
InChIKey
LJRDOKAZOAKLDU-UDXJMMFXSA-N
Molecular formula
C23H47N5O18S
Average molar mass
713.7 g/mol
Monoisotopic mass
713.26368084

Overview

Paromomycin sulfate is an aminoglycoside sulfate salt resulting from the treatment of paromomycin with sulfuric acid. A broad-spectrum antibiotic, it is used for the treatment of acute and chronic intestinal protozoal infections, but is not effective for extraintestinal protozoal infections. It is also used as a therapeutic against visceral leishmaniasis. It has a role as an antiparasitic agent, an anthelminthic drug, an antiprotozoal drug and an antibacterial drug. It is functionally related to a paromomycin.

Names & identifiers

Preferred name
Paromomycin Sulfate
IUPAC
(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol;sulfuric acid
English name
PAROMOMYCIN SULFATE
Molecular formula
C23H47N5O18S
Molecular weight
713.71

Names & synonyms

Paromomycin sulfate1263-89-4GabbromicinaGabbroralHumagelAminosidin sulfateAminosidine sulfateAminoxidinFarmiglucinFarminosidinSinosidAminosidine sulphate
Show more names
sulfhumatinNEOMYCIN EPAROMOMYCIN SULFATE SALTNeomycin Sulfate EP Impurity EO - 2, 6 - Diamino - 2, 6 - dideoxy - b - L - idopyranosyl - (1,3) - O - b - D - ribofuranosyl - (1,5) - O - [2 - amino - 2 - deoxy - a - D - glucopyranosyl - (1,4) ] - 2 - deoxy - streptamine sulfatefi5853D00868
PargonylHumycin sulfateParomomycin sulphateParamicinaParicina845NU6GJPSGabbromycin1600 Antibiotic

Database identifiers

CAS

Properties

Computed structural properties

Topological polar surface area
430 Ų
Hydrogen bond donors
15
Hydrogen bond acceptors
23
Rotatable bonds
9
Heavy atoms
47
Formal charge
0
Complexity
952

Experimental & physicochemical properties

Human Drugs · 3 items

Breast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Amebicides; Anti-Bacterial Agents; Aminoglycosides

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Physicochemical properties

Melting point
145 °C · 145 °C (decomp)
alpha
25 · D25 +50.5° (c = 1.5 in water pH 6)
storage temp.
Keep in dark place,Inert atmosphere,Room temperature
solubility
2 O: · H2O: 50 mg/mL store stock solution at 2-8°C. Stable at 37°C for 5 days.
form
powder
color
White to Off-White
Water Solubility
Soluble in water
Merck
14 · 14,7041
BRN
5715182 · 5715182
Stability
Hygroscopic
InChIKey
LJRDOKAZOAKLDU-UDXJMMFXSA-N

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 3 items

This chemical does not meet GHS hazard criteria for 93% (53 of 57) of all reports.

Not Classified

Aggregated GHS information provided per 57 reports by companies from 5 notifications to the ECHA C&L Inventory.

Hazard information

Regulatory InformationRegulation (EC) No 1831/2003 (amended)
Hazard Classes and CategoriesNot Classified

Toxicology

Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Paromomycin sulfate

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Safety data

wgk
2
rtecs
WK2320000
hs_code
2941901010
Toxicity
LD50 in mice (mg/kg): ~15,000 orally; 700 s.c.; 110 i.v. (Di Marco, Bertazzoli)
risk_code
23/24/25-36/38-39/23/24/25-61-36/37/38
Signal word
Warning
Symbol(GHS)
GHS07

Chemistry & industry

Pharmacology

FDA Pharmacological Classification · 2 items

PAROMOMYCIN SULFATE

Antiprotozoal [EPC]

MeSH Pharmacological Classification · 2 items

Substances that are destructive to protozoans.

Substances that inhibit the growth or reproduction of BACTERIA.

Applications · 5 items

DescriptionParomomycin was found in the culture broth of Streptomyces rimosus forma paromomycinus by Parke Davis & Co. in 1959. In the same year it was found in the culture broth of S. Crestomyceticus by Farmitalia and named amminosidin. Paromomycin is related structurally to neomycin, but it has a hydroxyl group at the 6 position, whereas neomycin has an amino group. Its antibacterial activity is weaker than that of neomycin, but its toxicity is much less. Paromomycin is used by intramuscular injection for therapy of respiratory, urinary, and surgical infections and by oral administration to treat dysentery and salmonellosis.

UsesPAROMOMYCIN SULFATE is an aminogycoside antibiotic designed to fight intestinal infections such as cryptosporidiosis, amoebiasis, and leishmaniasis. Its antiprotozoal activity makes it an effecive histomonostatic feed addit ive in turkey poults experimentally infected with Histomonas meleagridis.

Usesantibacterial, antiamebic

Usespolymeric nonionic detergent

General DescriptionChemical structure: aminoglycoside

Additional notes · 1 item

DefinitionChEBI: An aminoglycoside sulfate salt resulting from the treatment of paromomycin with sulfuric acid. A broad-spectrum antibiotic, it is used for the treatment of acute and chronic intestinal protozoal infections, but is not effective for extraintestinal protozoa infections. It is also used as a therapeutic against visceral leishmaniasis.

Related reactions

2 records
New reaction record
HRID 1949611 reaction equation
HRID 1949611As reactant
HRID 1949615 reaction equation
HRID 1949615As reactant

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
1263-89-4、7205-49-4
PubChem CID
441375
DTXSID
DTXSID601335979
ChEMBL
CHEMBL2206196
ChEBI
CHEBI:7935
UNII
845NU6GJPS
EC Number
215-031-7、230-575-5
CAS DataBase Reference
1263 · 1263-89-4
FDA UNII
845 NU6GJPS · 845NU6GJPS
NCI Drug Dictionary
Humatin
EPA Substance Registry System
Paromomycin sulfate (1263-89-4)
UNSPSC Code
12352200 · 12352200
NACRES
72 · NA.72
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
315 · H315-H319-H335
Precautionary statements
261 · P261-P280a-P304+P340-P305+P351+P338-P405-P501a
Hazard Codes
Xi
Risk Statements
23 · 23/24/25-36/38-39/23/24/25-61-36/37/38
Safety Statements
26 · 26-36/37-45-38-36
WGK Germany
2 · 2
RTECS
2320000 · WK2320000
HS Code
2941901010 · 2941901010
Storage Class
11 · 11 - Combustible Solids
Toxicity
50 in · LD50 in mice (mg/kg): ~15,000 orally; 700 s.c.; 110 i.v. (Di Marco, Bertazzoli)
hazard_code
Xi
safety_code
26-36/37-45-38-36
Storage Class
11 - Combustible Solids
Hazard statements
H315-H319-H335
Precautionary statements
P261-P280a-P304+P340-P305+P351+P338-P405-P501a